Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AGS-2010
- Development stage
- Preclinical
- Lead developer
- AGS Tx
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Oral
01
Overview
AGS-2010 is an investigational therapeutic candidate developed by AGS Therapeutics for the treatment of Inflammatory Bowel Disease (IBD). The drug utilizes the company's proprietary Membrane Extracellular Vesicles (MEV) platform, which employs microalgae-derived extracellular vesicles as a delivery vehicle for therapeutic payloads. These MEVs are designed to be robust, stable, and capable of delivering diverse molecules—such as proteins, nucleic acids, or small molecules—directly to target tissues while minimizing systemic side effects. For IBD, the platform is optimized for oral administration to ensure localized delivery within the gastrointestinal tract. As of early 2024, AGS-2010 is in the IND-enabling stage of development.
- Other names
- AGS-2010-A.G.S-MEVAGS2010-A.G.S-MEVAGS 2010-A.G.S-MEVAGS-2010-MEV-IBDAGS2010-MEV-IBDAGS 2010-MEV-IBD
Beyond the preview
Go deeper on AGS-2010.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AGS-2010.